Prognostic value of histopathology, stromal tumor infiltrating lymphocytes (sTILs) and adjuvant chemotherapy (AdjCT) in early stage triple negative breast cancer (TNBC).

被引：0
|
作者：
Leon-Ferre, Roberto Antonio
Polley, Mei-Yin
Liu, Heshan
Gilbert, Judith A.
Cafourek, Victoria
Hillman, David W.
Elkhanany, Ahmed
Akinhanmi, Margaret
Negron, Vivian
Boughey, Judy Caroline
Liu, Minetta C.
Ingle, James N.
Kalari, Krishna R.
Couch, Fergus
Visscher, Daniel W.
Goetz, Matthew P.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Alliance Stat, Rochester, MN USA
[3] Mayo Clin, Ctr Data, Rochester, MN USA
[4] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
533
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer-Reply
    Leon-Ferre, Roberto A.
    Salgado, Roberto
    Jonas, Sarah Flora
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (04): : 337 - 338
  • [42] Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
    Sherene Loi
    Roberto Salgado
    Sylvia Adams
    Giancarlo Pruneri
    Prudence A. Francis
    Magali Lacroix-Triki
    Heikki Joensuu
    Maria Vittoria Dieci
    Sunil Badve
    Sandra Demaria
    Robert Gray
    Elisabetta Munzone
    Damien Drubay
    Jerome Lemonnier
    Christos Sotiriou
    Pirkko Liisa Kellokumpu-Lehtinen
    Andrea Vingiani
    Kathryn Gray
    Fabrice André
    Carsten Denkert
    Martine Piccart
    Elvire Roblin
    Stefan Michiels
    npj Breast Cancer, 8
  • [43] Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC)
    Wein, Lironne
    Loi, Sherene
    BREAST, 2017, 34 : S27 - S30
  • [44] EFFICACY OF ADJUVANT VERSUS NEOADJUVANT CHEMOTHERAPY IN HISPANIC/LATINO WOMEN WITH EARLY STAGE, TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Philipovskiy, A.
    Corral, J.
    Heydariana, R.
    Gaur, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 593 - 593
  • [45] Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast Cancer
    Abuhadra, Nour
    Sun, Ryan
    Litton, Jennifer K.
    Rauch, Gaiane M.
    Yam, Clinton
    Chang, Jeffrey T.
    Seth, Sahil
    Bassett, Roland, Jr.
    Lim, Bora
    Thompson, Alastair M.
    Mittendorf, Elizabeth
    Adrada, Beatriz E.
    Damodaran, Senthil
    White, Jason
    Ravenberg, Elizabeth
    Candelaria, Rosalind
    Arun, Banu
    Ueno, Naoto T.
    Santiago, Lumarie
    Saleem, Sadia
    Abouharb, Sausan
    Murthy, Rashmi K.
    Ibrahim, Nuhad
    Sahin, Aysegul A.
    Valero, Vicente
    Symmans, William Fraser
    Tripathy, Debu
    Moulder, Stacy
    Huo, Lei
    CANCERS, 2022, 14 (05)
  • [46] Evaluation of the prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers
    Tian, Tian
    Ruan, Miao
    Yang, Wentao
    Shui, Ruohong
    ONCOTARGET, 2016, 7 (28) : 44395 - 44405
  • [47] Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
    de Jong, Vincent M. T.
    Wang, Yuwei
    ter Hoeve, Natalie D.
    Opdam, Mark
    Stathonikos, Nikolas
    Jozwiak, Katarzyna
    Hauptmann, Michael
    Cornelissen, Sten
    Vreuls, Willem
    Rosenberg, Efraim H.
    Koop, Esther A.
    Varga, Zsuzsanna
    van Deurzen, Carolien H. M.
    Mooyaart, Antien L.
    Cordoba, Alicia
    Groen, Emma J.
    Bart, Joost
    Willems, Stefan M.
    Zolota, Vasiliki
    Wesseling, Jelle
    Sapino, Anna
    Chmielik, Ewa
    Ryska, Ales
    Broeks, Annegien
    Voogd, Adri C.
    Loi, Sherene
    Michiels, Stefan
    Sonke, Gabe S.
    van der Wall, Elsken
    Siesling, Sabine
    van Diest, Paul J.
    Schmidt, Marjanka K.
    Kok, Marleen
    Dackus, Gwen M. H. E.
    Salgado, Roberto
    Linn, Sabine C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2361 - +
  • [48] Tumor-infiltrating lymphocytes in triple negative breast cancer
    Zakhartseva, L. M.
    Yanovytska, M. O.
    PATHOLOGIA, 2020, (03): : 287 - 294
  • [49] Tumor-infiltrating lymphocytes (TILs) for prediction of response to platinum-based neo-adjuvant chemotherapy (NACT) in triple-negative breast cancer (TNBC)
    Abdullaeva, Sheyda
    Semiglazova, Tatiana
    Artemyeva, Anna
    Semiglazov, Vladislav
    Krivorotko, Petr
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [50] Tumor infiltrating lymphocytes in recurrent HER2+and triple negative breast cancer: Prognostic value according to tumor phenotype
    Dieci, M. V.
    Giaratano, T.
    Miglietta, F.
    Griguolo, G.
    Orvieto, E.
    Falci, C.
    Giorgi, C. A.
    Mioranza, E.
    Tasca, G.
    Cappellesso, R.
    Ghiotto, C.
    Conte, P.
    Guarneri, V.
    CANCER RESEARCH, 2017, 77
12345